L
58
7
MET
64
7
CCI
31
-5
GLW
52
4
BBY
55
12
D
43
2
GPC
43
2
CAG
34
7
HAL
60
3
PGR
68
4
DHI
56
-4
KEY
43
7
GOOG
69
4
FITB
55
3
ORCL
65
2
DOW
58
4
HST
50
6
M
37
6
EXC
66
-4
UAL
73
7
L
58
7
MET
64
7
CCI
31
-5
GLW
52
4
BBY
55
12
D
43
2
GPC
43
2
CAG
34
7
HAL
60
3
PGR
68
4
DHI
56
-4
KEY
43
7
GOOG
69
4
FITB
55
3
ORCL
65
2
DOW
58
4
HST
50
6
M
37
6
EXC
66
-4
UAL
73
7
Financhill
Back

Blueprint Medicines Vs. Cytokinetics Industry Stock Comparison

Sell
30

BPMC
Blueprint Medicines

Last Price:
88.69
Seasonality Move:
10.1%
Sell
50

CYTK
Cytokinetics

Last Price:
56.69
Seasonality Move:
7.34%
Sell
30
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $88.58. The Score for BPMC is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $56.68. The Score for CYTK is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $88.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight selling pressure.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $56.68
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.96 Sell
Relative Strength Index (14 RSI): 45.15 Sell
Chaikin Money Flow: -108029 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.66 - 92.08) Sell
Bollinger Bands (100): (91.1 - 110.3) Sell

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.34 Sell
Relative Strength Index (14 RSI): 59.55 Buy
Chaikin Money Flow: 736471 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.88 - 56.02) Buy
Bollinger Bands (100): (52.1 - 57.86) Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 89.81 Sell
20-day SMA: 88.79 Sell
50-day SMA: 92.93 Sell
200-day SMA: 94.84 Sell
8-day EMA: 89.6 Sell
20-day EMA: 90.04 Sell
50-day EMA: 93.45 Sell
200-day EMA: 91.2 Sell

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.51 Buy
20-day SMA: 54.24 Buy
50-day SMA: 55.46 Buy
200-day SMA: 63.82 Sell
8-day EMA: 54.26 Buy
20-day EMA: 54.31 Buy
50-day EMA: 55.1 Buy
200-day EMA: 56.13 Buy

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.52 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.28 per share, and a decrease next year of $0.18 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.28 per share, and an increase next year of $0.22 per share.

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):